The global UV infection control devices market was valued at $317.42 million in 2018, and is projected to reach $524.84 million by 2026, registering a CAGR of 6.5% from 2019 to 2026.
The UV infection control device is one of the disinfectant systems that use ultraviolet rays to kill microorganism present in the various healthcare setting such as hospitals, clinics, ambulatory surgical centers, research center, emergency departments, and others. As health care-associated infections (HAIs) is rising every year, which are caused by microorganisms such as fungi, bacteria, viruses, and parasites that can affect patients seriously. The UV infection control device works base on UV light that reflects off walls and other surfaces and is absorbed by bacteria, whose light-sensitive porphyrin molecules become excited and, as a result, experience oxidative damage and cell death.
The major factor that contributes to the growth of UV infection control device market include increase in government focus on infection control programs and an increase in the The prevalence of hospital acquired infections (HAI). Furthermore, other factors that boost UV infection control device market growth include rising adoption of technologically advanced UV equipment. However, the high cost of UV infection control devices and stringent government regulations hampers the growth of UV infection control devices market. Conversely, high growth potential in developing economies is expected to offer lucrative opportunities during the forecast period.
The UV infection control devices market size is studied on the basis of type, end users, and region. By type, the market is bifurcated into mobile, stationary, and other types. By end user, the market is segmented into hospitals, clinics, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Russia, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
Key Market Segments
By Type
By End User
By Region
List of key players profiled in the report:
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
The UV infection control device is one of the disinfectant systems that use ultraviolet rays to kill microorganism present in the various healthcare setting such as hospitals, clinics, ambulatory surgical centers, research center, emergency departments, and others. As health care-associated infections (HAIs) is rising every year, which are caused by microorganisms such as fungi, bacteria, viruses, and parasites that can affect patients seriously. The UV infection control device works base on UV light that reflects off walls and other surfaces and is absorbed by bacteria, whose light-sensitive porphyrin molecules become excited and, as a result, experience oxidative damage and cell death.
The major factor that contributes to the growth of UV infection control device market include increase in government focus on infection control programs and an increase in the The prevalence of hospital acquired infections (HAI). Furthermore, other factors that boost UV infection control device market growth include rising adoption of technologically advanced UV equipment. However, the high cost of UV infection control devices and stringent government regulations hampers the growth of UV infection control devices market. Conversely, high growth potential in developing economies is expected to offer lucrative opportunities during the forecast period.
The UV infection control devices market size is studied on the basis of type, end users, and region. By type, the market is bifurcated into mobile, stationary, and other types. By end user, the market is segmented into hospitals, clinics, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Russia, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
- This report entails a detailed quantitative analysis along with the current global UV infection control devices market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessments.
- The market size and estimations are based on a comprehensive analysis of key developments in the industry.
- A qualitative analysis based on innovative products facilitates strategic business planning.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market
Key Market Segments
By Type
- Mobile
- Stationary
- Other types
By End User
- Hospitals
- Clinics
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- Russia
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
List of key players profiled in the report:
- CVS Health Corporation
- DocMorris
- Express Scripts Holding Company
- Giant Eagle Inc.
- Optum Rx Inc.
- Rowlands Pharmacy
- The Kroger Co.
- Walgreen Co.
- Walmart Stores Inc.
- Apollo Pharmacy
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
- The Miele Group
- Melag Medizintechnik OHG
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: UV INFECTION CONTROL DEVICES MARKET, BY TYPE
CHAPTER 5: GLOBAL UV INFECTION CONTROL DEVICES MARKET, BY END USER
CHAPTER 6: UV INFECTION CONTROL DEVICES MARKET, BY REGION
CHAPTER 7: COMPANY PROFILES
Executive Summary
According to this report titled, 'UV Infection Control Devices Market by Type, and End User: Global Opportunity Analysis and Industry Forecast, 2018-2026,' the global UV infection control devices market size was valued at $317 million in 2018, and is projected to reach $525 million by 2026, registering a CAGR of 6.5% from 2019 to 2026.UV infection control devices emit ultraviolet rays that can kill infection causing microorganisms present in various healthcare facilities such as hospitals, clinics, and others. Furthermore, there are different types of UV infection control devices available in the market. For instance, mobile UV infection control devices are portable and can be moved from one place to another easily. In addition, the devices have h andles all around which aid in the movement of device from one location to another. However, station type UV infection control devices are designed to plug into a st andard power outlet. Moreover, these devices work by reflecting UV light off the walls. This reflected light is then absorbed by bacteria, whose light-sensitive porphyrin molecules become excited and, as a result, experience oxidative damage and cell death.
Surge in government focus on infection control programs and an increase in the The prevalence of hospital acquired infections (HAI) are the major factors that contribute to the growth of the UV infection control devices market. Furthermore, a rise in the adoption of technologically advanced UV equipment further supplement the growth of the market. However, high cost of UV infection control devices and stringent government regulations hinder the growth of the market globally. On the contrary, high growth prospects in emerging markets can provide newer opportunities for the UV infection control devices market growth.
The global UV infection control devices market is segmented on the basis of type, end users, and region. By type, the market is bifurcated into mobile, stationary, and other types. By end user, the market is segmented into hospitals, clinics, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Russia, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA).
By type, the mobile type segment holds the dominant position in 2018 and would continue to maintain the lead over the forecast period. This is attributed to its mobility; as the device is light and can be moved to different settings. In addition, the cost of mobile UV infection control devices is less expensive than the stationary IV infection control devices. Furthermore, these mobile units are specifically designed for the ease of use and elimination of human error. For instance, mobile UV infection devices are available with casters or with a h andcarts for maximum mobility. Therefore, the factors aforementioned contribute to the growth of the market.
By end user, the hospital segment occupied the largest share of the UV infection control devices market in 2018 owing to factors such as a rise in the number of UV infection control devices are used in the medical devices due to surge in cases of hospital acquired infections. In addition, surge in number of hospitals worldwide is further supporting the market growth. Hospital segment is also the fastest growing end user segment in UV infection control devices market.
North America accounted for the major UV infection control devices market share in 2018 and is expected to continue this trend, owing to presence of well-established healthcare infrastructure, higher buying power, and high adoption of advanced medical equipment. In addition, rise in cases of hospital acquired infection (HAIs) is another major factor that boost the growth of the market. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period attributed to the highly populated countries, with China being the first and India the second most populated countries. Therefore, the region has the potential to offer a huge patient base which is expected to boost the growth of the Asia-Pacific UV infection control devices market.
Key Findings of the Study:
By type, the mobile device segment occupied around half share of the global UV infection control devices market in 2018.
By end user, the hospitals segment is anticipated to grow with the highest CAGR throughout the forecast period.
By type, the others segment accounted for more than two-fifths share of the market in 2018.
BY region, Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.
Companies Mentioned
- CVS Health Corporation
- DocMorris
- Express Scripts Holding Company
- Giant Eagle Inc.
- Optum Rx Inc.
- Rowlands Pharmacy
- The Kroger Co.
- Walgreen Co.
- Walmart Stores Inc.
- Apollo Pharmac
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 154 |
| Published | March 2020 |
| Forecast Period | 2018 - 2026 |
| Estimated Market Value ( USD | $ 317.42 million |
| Forecasted Market Value ( USD | $ 524.84 million |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
